Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Projects actively recruiting
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022-2024
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Converging priorities in an expanding global genomics landscape

Home All news & events News Converging priorities in an expanding global…

An analysis of national human genomics programs across seven countries has identified common priorities and barriers to implementing genomic medicine globally.

The programs span Genomics England; Genome Canada; the National Human Genome Research Institute (USA); Precision Health Research, Singapore (PRECISE); the Danish National Genome Center; the Qatar Genome Program; and Australian Genomics.

The expanding global genomics landscape: Converging priorities from national genomics programs is published in the latest edition of The American Journal of Human Genetics.

While emphasising there is no “one-size-fits-all” approach – programs are designed to address local issues and health systems – the paper identifies six priority areas shared by seven countries’ active genomic programs and gives examples of these.

The priorities span participant involvement and public engagement; ethical, legal and social considerations; increasing diversity across studies and programs; virtuous cycles for implementing genomic medicine; data infrastructure; prioritising funding and new technologies.

All national and international programs vary in their level of maturity, funding sources and strategies, but in a rapidly expanding health genomics landscape, many of these converge, the paper finds.

Read the paper here.